ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

BACKGROUND: The expression of ZFP36 in previous study was reduced in prostate cancer (PCa) tissues as compared to benign prostate tissues, indicating the potential of ZFP36 as an auxiliary marker for PCa. Further evaluation was conducted in clinical samples for in vitro and in vivo experiments, to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Dongbo, Fang, Yinyi, Chen, Weiming, Jiang, Kehua, Zhu, Guohua, Wang, Wei, Zhang, Wei, You, Ganhua, Jia, Zhenyu, Zhu, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470309/
https://www.ncbi.nlm.nih.gov/pubmed/36111167
http://dx.doi.org/10.1155/2022/3611540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470309/
https://www.ncbi.nlm.nih.gov/pubmed/36111167
http://dx.doi.org/10.1155/2022/3611540

Ejemplares similares